oxymetazoline rosacea Rhofade
Selected indexed studies
- Rosacea management: A comprehensive review. (J Cosmet Dermatol, 2022) [PMID:35104917]
- S2k guideline: Rosacea. (J Dtsch Dermatol Ges, 2022) [PMID:35929658]
- Oxymetazoline cream (Rhofade) for rosacea. (Med Lett Drugs Ther, 2017) [PMID:28520699]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Rosacea management: A comprehensive review. (2022) pubmed
- S2k guideline: Rosacea. (2022) pubmed
- Rosacea: An Update in Diagnosis, Classification and Management. (2021) pubmed
- Interventions for rosacea based on the phenotype approach: an updated systematic review including GRADE assessments. (2019) pubmed
- Role of Topical Oxymetazoline for Management of Erythematotelangiectatic Rosacea. (2018) pubmed
- Oxymetazoline (topical): rosacea. (2013) pubmed
- Oxymetazoline hydrochloride cream for facial erythema associated with rosacea. (2017) pubmed
- Oxymetazoline cream (Rhofade) for rosacea. (2017) pubmed
- Oxymetazoline Hydrochloride 1% Cream (Rhofade) for Persistent Facial Erythema Associated with Rosacea. (2018) pubmed
- Efficacy and safety of oxymetazoline for the treatment of rosacea: A meta-analysis. (2023) pubmed